Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1896 1
1929 1
1934 1
1935 2
1946 2
1949 2
1950 3
1951 4
1954 2
1955 1
1958 2
1959 2
1960 2
1961 3
1962 2
1963 4
1964 1
1965 5
1966 7
1967 6
1968 6
1969 8
1970 12
1971 6
1972 7
1973 7
1974 2
1975 8
1976 3
1977 4
1978 7
1979 9
1980 3
1981 5
1982 4
1983 4
1984 8
1985 9
1986 4
1987 3
1988 6
1989 11
1990 5
1991 4
1992 3
1993 7
1994 2
1995 13
1996 15
1997 8
1998 11
1999 11
2000 6
2001 3
2002 9
2003 7
2004 8
2005 5
2006 10
2007 10
2008 6
2009 4
2010 5
2011 5
2012 4
2013 10
2014 4
2015 5
2016 7
2017 7
2018 13
2019 9
2020 5
2021 13
2022 7
2023 15
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

432 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous T-cell lymphoma: diagnosing subtypes and the challenges.
Hague C, Farquharson N, Menasce L, Parry E, Cowan R. Hague C, et al. Among authors: parry e. Br J Hosp Med (Lond). 2022 Apr 2;83(4):1-7. doi: 10.12968/hmed.2021.0149. Epub 2022 Apr 14. Br J Hosp Med (Lond). 2022. PMID: 35506718 Review.
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
Parry EM, Leshchiner I, Guièze R, Johnson C, Tausch E, Parikh SA, Lemvigh C, Broséus J, Hergalant S, Messer C, Utro F, Levovitz C, Rhrissorrakrai K, Li L, Rosebrock D, Yin S, Deng S, Slowik K, Jacobs R, Huang T, Li S, Fell G, Redd R, Lin Z, Knisbacher BA, Livitz D, Schneider C, Ruthen N, Elagina L, Taylor-Weiner A, Persaud B, Martinez A, Fernandes SM, Purroy N, Anandappa AJ, Ma J, Hess J, Rassenti LZ, Kipps TJ, Jain N, Wierda W, Cymbalista F, Feugier P, Kay NE, Livak KJ, Danysh BP, Stewart C, Neuberg D, Davids MS, Brown JR, Parida L, Stilgenbauer S, Getz G, Wu CJ. Parry EM, et al. Nat Med. 2023 Jan;29(1):158-169. doi: 10.1038/s41591-022-02113-6. Epub 2023 Jan 9. Nat Med. 2023. PMID: 36624313 Free PMC article.
Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome.
Davids MS, Rogers KA, Tyekucheva S, Wang Z, Pazienza S, Renner SK, Montegaard J, Ihuoma U, Lehmberg TZ, Parry EM, Wu CJ, Jacobson CA, Fisher DC, Thompson PA, Brown JR. Davids MS, et al. Among authors: parry em. Blood. 2022 Feb 3;139(5):686-689. doi: 10.1182/blood.2021011386. Blood. 2022. PMID: 34788401 Free PMC article. Clinical Trial.
ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.
Parry EM, Lemvigh CK, Deng S, Dangle N, Ruthen N, Knisbacher BA, Broséus J, Hergalant S, Guièze R, Li S, Zhang W, Johnson C, Long JM, Yin S, Werner L, Anandappa A, Purroy N, Gohil S, Oliveira G, Bachireddy P, Shukla SA, Huang T, Khoury JD, Thakral B, Dickinson M, Tam C, Livak KJ, Getz G, Neuberg D, Feugier P, Kharchenko P, Wierda W, Olsen LR, Jain N, Wu CJ. Parry EM, et al. Cancer Cell. 2023 Oct 9;41(10):1803-1816.e8. doi: 10.1016/j.ccell.2023.08.013. Epub 2023 Sep 21. Cancer Cell. 2023. PMID: 37738974
A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL.
Jain N, Senapati J, Thakral B, Ferrajoli A, Thompson P, Burger J, Basu S, Kadia T, Daver N, Borthakur G, Konopleva M, Pemmaraju N, Parry E, Wu CJ, Khoury J, Bueso-Ramos C, Garg N, Wang X, Lopez W, Ayala A, O'Brien S, Kantarjian H, Keating M, Allison J, Sharma P, Wierda W. Jain N, et al. Among authors: parry e. Blood Adv. 2023 May 23;7(10):1958-1966. doi: 10.1182/bloodadvances.2022008790. Blood Adv. 2023. PMID: 36287248 Free PMC article. Clinical Trial.
Louse-borne relapsing fever.
Bryceson AD, Parry EH, Perine PL, Warrell DA, Vukotich D, Leithead CS. Bryceson AD, et al. Among authors: parry eh. Q J Med. 1970 Jan;39(153):129-70. Q J Med. 1970. PMID: 4913454 Review. No abstract available.
Disasters.
Dick B, Parry E. Dick B, et al. Among authors: parry e. Trop Doct. 1991;21 Suppl 1:1-4. doi: 10.1177/00494755910210S101. Trop Doct. 1991. PMID: 1882422 No abstract available.
Chevron nail/herringbone nail.
Parry EJ. Parry EJ. J Am Acad Dermatol. 1999 Mar;40(3):497-8. doi: 10.1016/s0190-9622(99)70511-6. J Am Acad Dermatol. 1999. PMID: 10071331 No abstract available.
432 results